Leeds Assessment of Neuropathic Symptoms and Signs (LANSS)
This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (26/07/2023)
Original Editor - Melissa Coetsee
Top Contributors - Melissa Coetsee
Objective[edit | edit source]
The LANSS was developed to provide a simple clinical tool that can be used to distinguish between neuropathic pain and nociceptive pain - it is used to determine whether neuropathic mechanisms dominate a patient's pain experience[1]. By identifying neuropathic pain mechanisms, more individualised treatment can follow. It was developed in 2001, and an alternative scale,
Intended Population[edit | edit source]
Method of Use[edit | edit source]
Reference[edit | edit source]
Evidence[edit | edit source]
Reliability[edit | edit source]
Validity[edit | edit source]
Responsiveness[edit | edit source]
Miscellaneous[edit | edit source]
Links[edit | edit source]
References[edit | edit source]
- ↑ Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001 May 1;92(1-2):147-57.
